Gaps in the nation's stroke transfer system are drastically reducing survivors' chances of receiving critical treatment and increasing the likelihood ...
Gaps in the U.S. stroke transfer system are drastically reducing survivors' chances of receiving critical treatment and increasing the likelihood that ...
Ischemic Stroke in Atrial Fibrillation: Detection by ECG at Admission versus Prolonged Monitoring ()
Introduction: Atrial fibrillation (AF) is a major risk factor for ischemic stroke (IS). Its diagnosis can be challenging, ...
A nearly 30-year study shows a strong long-term association between very high lipoprotein(a) levels and cardiovascular ...
MedPage Today on MSN
DVT assessment strategy safely expands rule-out
Study validates age-adjusted D-dimer cutoff for ruling out leg deep vein thrombosis ...
NEW YORK, Dec 29 (Reuters) - The Trump administration on Monday reached a deal with researchers and Democratic-led states who sued over cuts to funding for diversity-related research, agreeing to ...
Jonathan Wosen is STAT’s West Coast biotech & life sciences reporter. You can reach Jonathan on Signal at jwosen.27. Walter Koroshetz, director of the National Institute of Neurological Disorders and ...
Anil Oza is a general assignment reporter at STAT focused on the NIH and health equity. You can reach him on Signal at aniloza.16. Jonathan Wosen is STAT’s West Coast biotech & life sciences reporter.
What is the effectiveness of the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs at the National Institutes of Health (NIH)? An ad hoc committee will ...
Over the past two decades, scientists developed a pandemic preparedness playbook that has failed catastrophically. It grew out of the fears aroused by the global emergence of highly pathogenic avian ...
US-based biopharma Silver Creek Pharmaceuticals’ late intervention acute ischemic stroke candidate, SCP-776, has demonstrated varied results in a mid-stage trial. During the Phase II ARPEGGIO ...
RESEARCH TRIANGLE, N.C., Oct. 22, 2025 /PRNewswire/ -- Basking Biosciences (Basking), a clinical-stage biopharmaceutical company developing the first reversible thrombolytic therapy for acute ischemic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback